Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10434136 Powerful MHC-class II peptides derived from survivin

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
June 28, 2013
Date of Patent
October 8, 2019
Patent Application Number
13931413
Patent Citations Received
‌
US Patent 11833194 Peptides and combination of peptides for use in immunotherapy against various cancers
0
‌
US Patent 11963990 Oncolytic viruses for modified MHC expression
0
‌
US Patent 11065314 Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
‌
US Patent 11666644 Peptide vaccines
0
‌
US Patent 11759507 Personalized immunotherapy against several neuronal and brain tumors
‌
US Patent 12016893 Oncolytic viruses for modified MHC expression
0
‌
US Patent 11840562 Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
0
‌
US Patent 11779606 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
‌
US Patent 11801264 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
‌
US Patent 11786584 Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
•••
Patent Inventor Names
Peter Lewandrowski
0
Cecile Gouttefangeas
0
Hans-Georg Rammensee
0
Stefan Stevanovic
0
Toni Weinschenk
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10434136
Patent Primary Examiner
‌
Michael Szperka

Find more entities like US Patent 10434136 Powerful MHC-class II peptides derived from survivin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.